Literature DB >> 25540048

Expression of V(H)-linker-V(L) orientation-dependent single-chain Fv antibody fragment derived from hybridoma 2E6 against aflatoxin B1 in Escherichia coli.

Aiping Liu1, Yang Ye, Weifeng Chen, Xiaohong Wang, Fusheng Chen.   

Abstract

Aflatoxin B1 (AFB1) is a toxic secondary metabolic product, which threatens human and animal health. Antibody is a key factor for immunoassay against toxic stuff like AFB1, and single-chain Fv antibody fragment (scFv) has become a popular format of genetically engineered antibody. In this study, four hybridoma cell lines against AFB1 were obtained, and then scFvs 2E6 derived from hybridoma cell line 2E6 were constructed in different V(H)/V(L) orientations. Subsequently, scFvs 2E6 were expressed in E. coli BL21(DE3) mainly in the form of inclusion body. SDS-PAGE, Western blot and ELISA were employed to characterize scFvs 2E6. The results revealed that the yield of inclusion body of scFvs 2E6 in either V(H)/V(L) orientation was similar; however, only the scFv in V(H)-linker-V(L) orientation showed anti-AFB1 bioactivity after refolding. The present study underscores the importance of choosing optimal V(H)/V(L) orientation for scFv construction, and scFv may be favorable for immunoassays in food industry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25540048     DOI: 10.1007/s10295-014-1570-9

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  33 in total

1.  Some traditional herbal medicines, some mycotoxins, naphthalene and styrene.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2002

Review 2.  Combined toxic effects of mycotoxins.

Authors:  G J A Speijers; M H M Speijers
Journal:  Toxicol Lett       Date:  2004-10-10       Impact factor: 4.372

Review 3.  Secondary metabolism and food intoxication--moulds.

Authors:  M O Moss
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1992

Review 4.  Mycotoxin production by Aspergillus, Fusarium and Penicillium species.

Authors:  M J Sweeney; A D Dobson
Journal:  Int J Food Microbiol       Date:  1998-09-08       Impact factor: 5.277

5.  Optimization of primer sequences for mouse scFv repertoire display library construction.

Authors:  H Zhou; R J Fisher; T S Papas
Journal:  Nucleic Acids Res       Date:  1994-03-11       Impact factor: 16.971

Review 6.  Making antibodies by phage display technology.

Authors:  G Winter; A D Griffiths; R E Hawkins; H R Hoogenboom
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Effect of the order of antibody variable regions on the expression of the single-chain HyHEL10 Fv fragment in E. coli and the thermodynamic analysis of its antigen-binding properties.

Authors:  K Tsumoto; Y Nakaoki; Y Ueda; K Ogasahara; K Yutani; K Watanabe; I Kumagai
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

Review 8.  Toxicity, metabolism, and impact of mycotoxins on humans and animals.

Authors:  H S Hussein; J M Brasel
Journal:  Toxicology       Date:  2001-10-15       Impact factor: 4.221

9.  Production and characterization of an active single-chain variable fragment antibody recognizing CD25.

Authors:  Hideki Muramatsu; Kazuhiro Yoshikawa; Takeshi Hayashi; Syuntaro Takasu; Yoichi Kawada; Kazuo Uchida; Shigeki Sato; Toshitada Takahashi; Shinsuke Saga; Ryuzo Ueda
Journal:  Cancer Lett       Date:  2005-01-23       Impact factor: 8.679

10.  A compact phage display human scFv library for selection of antibodies to a wide variety of antigens.

Authors:  Potjamas Pansri; Nanthnit Jaruseranee; Kuntalee Rangnoi; Peter Kristensen; Montarop Yamabhai
Journal:  BMC Biotechnol       Date:  2009-01-29       Impact factor: 2.563

View more
  8 in total

1.  One-Step Ultrasensitive Bioluminescent Enzyme Immunoassay Based on Nanobody/Nanoluciferase Fusion for Detection of Aflatoxin B1 in Cereal.

Authors:  Wenjie Ren; Zhenfeng Li; Yang Xu; Debin Wan; Bogdan Barnych; Yanping Li; Zhui Tu; Qinghua He; Jinheng Fu; Bruce D Hammock
Journal:  J Agric Food Chem       Date:  2019-04-24       Impact factor: 5.279

2.  Generation of single-chain Fv antibody fragments against Mu-2-related death-inducing gene in Escherichia coli.

Authors:  Dimuthu Dhammika Wickramanayake; Jun-Ha Choi; Juhyun Shin; Jae-Wook Oh
Journal:  Mol Biol Rep       Date:  2019-05-09       Impact factor: 2.316

3.  Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application.

Authors:  Wanuttha Boonyayothin; Khwanlada Kobtrakul; Petlada Khositanon; Sornkanok Vimolmangkang; Waranyoo Phoolcharoen
Journal:  Biotechnol Rep (Amst)       Date:  2022-03-26

Review 4.  Synthetic approach to the generation of antibody diversity.

Authors:  Hyunbo Shim
Journal:  BMB Rep       Date:  2015-09       Impact factor: 4.778

5.  A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.

Authors:  Ju-Lun Yang; Du-Xian Liu; Shi-Jian Zhen; Yun-Gang Zhou; Dai-Jun Zhang; Li-Ying Yang; Hao-Bing Chen; Qiang Feng
Journal:  BMC Cancer       Date:  2016-02-20       Impact factor: 4.430

6.  Designing and generating a single-chain fragment variable (scFv) antibody against IL2Rα (CD25): An in silico and in vitro study.

Authors:  Parnian Navabi; Mohamad Reza Ganjalikhany; Sepideh Jafari; Moein Dehbashi; Mazdak Ganjalikhani-Hakemi
Journal:  Iran J Basic Med Sci       Date:  2021-03       Impact factor: 2.699

7.  Camelization of a murine single-domain antibody against aflatoxin B1 and its antigen-binding analysis.

Authors:  Qian Pang; Yanhong Chen; Hina Mukhtar; Jing Xiong; Xiaohong Wang; Ting Xu; Bruce D Hammock; Jia Wang
Journal:  Mycotoxin Res       Date:  2022-01-13       Impact factor: 3.833

8.  Effects of variable domain orientation on anti-HER2 single-chain variable fragment antibody expressed in the Escherichia coli cytoplasm.

Authors:  İlkay Koçer; Emily C Cox; Matthew P DeLisa; Eda Çelik
Journal:  Biotechnol Prog       Date:  2020-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.